Compare · EW vs HDSN
EW vs HDSN
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Hudson Technologies Inc. (HDSN): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while HDSN operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $49.36B, about 190.2x HDSN ($259.6M).
- HDSN has been more active in the news (10 items in the past 4 weeks vs 7 for EW).
- EW has more recent analyst coverage (25 ratings vs 11 for HDSN).
- Company
- Edwards Lifesciences Corporation
- Hudson Technologies Inc.
- Price
- -
- -
- Market cap
- $49.36B
- $259.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 10
- Recent ratings
- 25
- 11
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Hudson Technologies Inc.
Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was founded in 1991 and is headquartered in Pearl River, New York.
Latest EW
- Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
- CVP, EMEACLA Bruls Annette covered exercise/tax liability with 109 shares, decreasing direct ownership by 0.53% to 20,628 units (SEC Form 4) (for withholding tax)
- CVP, Chief Financial Officer Mistras Theodora was granted 99,920 shares (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,762 worth of shares (619 units at $91.70) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 377 shares, decreasing direct ownership by 0.93% to 40,034 units (SEC Form 4) to cover taxes
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,577 worth of shares (619 units at $91.40) as part of a pre-agreed trading plan (SEC Form 4)
- Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
- CEO Zovighian Bernard J sold $45,982 worth of shares (523 units at $87.92) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 11-K filed by Edwards Lifesciences Corporation
- SEC Form 11-K filed by Edwards Lifesciences Corporation
Latest HDSN
- Amendment: SEC Form SCHEDULE 13G/A filed by Hudson Technologies Inc.
- Large owner Hartree Partners, Lp bought $31,352 worth of shares (5,234 units at $5.99), increasing direct ownership by 0.11% to 4,976,536 units (SEC Form 4)
- Large owner Hartree Partners, Lp bought $4,477,207 worth of shares (764,202 units at $5.86), increasing direct ownership by 18% to 4,971,302 units (SEC Form 4)
- New insider Hartree Partners, Lp claimed ownership of 4,207,100 shares (SEC Form 3)
- Director Sheriff Alan was granted 3,219 shares, increasing direct ownership by 35% to 12,484 units (SEC Form 4)
- Director Prouty Eric A was granted 4,440 shares, increasing direct ownership by 3% to 158,292 units (SEC Form 4)
- SEC Form 4 filed by Director Parrillo Richard
- Director Mansy Loan Nguyen was granted 8,881 shares, increasing direct ownership by 35% to 34,476 units (SEC Form 4)
- SEC Form 4 filed by Director Bulgarino Nicole E
- Director Feeler Jeffrey R was granted 3,219 shares, increasing direct ownership by 35% to 12,384 units (SEC Form 4)